Article info
PDFLaboratory science
Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity
- Correspondence to Prof. Hans-Peter Hammes, 5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany; hans-peter.hammes{at}med5.ma.uni-heidelberg.de
Citation
Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity
Publication history
- Accepted May 25, 2009
- First published August 27, 2009.
Online issue publication
April 12, 2010
Article Versions
- Previous version (27 August 2009).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.